Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients
- PMID: 9696487
- DOI: 10.1016/s0168-8278(98)80173-6
Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients
Abstract
Background/aims: The aim of this study was to evaluate the impact of the host immune status and of virological and environmental parameters on the development of cirrhosis during chronic hepatitis C virus infection.
Methods: Liver histology (cirrhosis or not, Knodell score) was evaluated according to age, sex, route and age of contamination, alcohol consumption and immune status in a large series of 553 HBsAg-negative patients (whose duration of hepatitis C virus infection could be precisely evaluated) divided into three groups: group 1 consisted of 462 immunocompetent subjects (46.1% intravenous drug users, 53.9% transfused), infected for a mean of 12.5+/-6.7 years, including 16.6% of alcohol abusers (>80 g/day); groups 2a and 2b consisted of 91 immunocompromised patients, 52 human immunodeficiency virus-coinfected patients corresponding to group 2a and 39 kidney recipients undergoing immunosuppressive therapy for group 2b, having been infected by hepatitis C virus for a mean of 12.6+/-5.3 and 11.5+/-5.3 years, respectively.
Results: Group 1: cirrhosis was present in 11.0% of group 1 patients and in 23.6% of immunocompetent patients with a duration of hepatitis C virus infection of 20 years or more. Forty-three percent of patients with cirrhosis and with hepatitis C virus infection for more than 20 years were alcohol abusers. The time taken to develop cirrhosis was 14+/-7 years in patients infected before the age of 40 years as compared to 8+/-5 years in those infected after 40 years (p<0.001). Groups 2a and 2b: cirrhosis was present in 19.8% of immunocompromised patients, a significantly higher rate than in immunocompetent patients (p<0.01). Alcohol abuse did not increase the risk of cirrhosis in this group. All patients but one were infected by hepatitis C virus before the age of 40 and the calculated time elapsed until the occurrence of cirrhosis was 12.4+/-5.5 years. In groups 1, 2a and 2b, there was no relation between histological severity, hepatitis C virus genotype and viral load. Four variables were independently associated with the occurrence of cirrhosis in the multivariate analysis: age over 40 at time of contamination (RR=9.3 in age range 40 to 59 and 91.2 in > or =60 years); long duration (> or =20 years) of hepatitis C virus infection (RR=15.4); alcohol consumption over 80 g/d (RR=2.9); and human immunodeficiency virus-coinfection (RR=2.6).
Conclusions: Our study on a large series of well-characterized patients provides an accurate evaluation of the risk of cirrhosis in parenterally-contaminated immunocompetent hepatitis C virus-infected patients, with an overall figure of 11%. It also demonstrates the impact of the host immune status on the risk of severe histological lesions during chronic hepatitis C virus infection. It finally establishes the importance of age at the time of viral infection in the occurrence of cirrhosis, as well as the importance of alcohol consumption. Thus, at least following parenteral infection, both host-related and environmental cofactors play a major role in the severity of the liver lesions associated with hepatitis C virus infection.
Similar articles
-
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.Hepatology. 2001 Dec;34(6):1193-9. doi: 10.1053/jhep.2001.29201. Hepatology. 2001. PMID: 11732009
-
Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.Transplantation. 1998 Apr 15;65(7):930-6. doi: 10.1097/00007890-199804150-00012. Transplantation. 1998. PMID: 9565097
-
[Rate of liver fibrosis progression among patients with chronic hepatitis C in Poland].Pol Arch Med Wewn. 2003 Aug;110(2):869-75. Pol Arch Med Wewn. 2003. PMID: 14682226 Polish.
-
Predicting progression to cirrhosis in chronic hepatitis C virus infection.J Viral Hepat. 2003 Jul;10(4):285-93. doi: 10.1046/j.1365-2893.2003.00436.x. J Viral Hepat. 2003. PMID: 12823595 Review.
-
Natural history of chronic hepatitis C.Ital J Gastroenterol Hepatol. 1999 Jan-Feb;31(1):28-44. Ital J Gastroenterol Hepatol. 1999. PMID: 10091101 Review.
Cited by
-
Recognition of genetic factors influencing the progression of hepatitis C : potential for personalized therapy.Mol Diagn Ther. 2008;12(4):209-18. doi: 10.1007/BF03256286. Mol Diagn Ther. 2008. PMID: 18652517 Review.
-
Hepatitis C and HIV-1 coinfection.Gut. 2002 Oct;51(4):601-8. doi: 10.1136/gut.51.4.601. Gut. 2002. PMID: 12235089 Free PMC article.
-
Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.Dig Dis Sci. 2001 Aug;46(8):1677-83. doi: 10.1023/a:1010697319589. Dig Dis Sci. 2001. PMID: 11508667
-
Plasma Hepatitis C Virus Viral Load Among Hepatitis C Virus Mono-Infected and HCV/HIV Co-Infected Individuals in Yunnan Province,China.Hepat Mon. 2012 Jul;12(7):453-9. doi: 10.5812/hepatmon.6160. Epub 2012 Jul 30. Hepat Mon. 2012. PMID: 23008726 Free PMC article.
-
Clinical Liver Disease Progression Among Hepatitis C-Infected Drug Users With CD4 Cell Count Less Than 200 Cells/mm(3) Is More Pronounced Among Women Than Men.Open Forum Infect Dis. 2015 Dec 31;3(1):ofv214. doi: 10.1093/ofid/ofv214. eCollection 2016 Jan. Open Forum Infect Dis. 2015. PMID: 26955643 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical